Victory Capital Management Inc. bought a new position in shares of Enhabit, Inc. (NYSE:EHAB – Get Rating) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 656,733 shares of the company's stock, valued at approximately $9,221,000. Victory Capital Management Inc. owned about 1.32% of Enhabit as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Maryland State Retirement & Pension System bought a new stake in Enhabit in the third quarter valued at about $340,000. OLD Mission Capital LLC bought a new stake in Enhabit in the second quarter valued at about $379,000. Wedge Capital Management L L P NC bought a new stake in Enhabit in the third quarter valued at about $5,854,000. Strs Ohio increased its holdings in shares of Enhabit by 187.5% in the third quarter. Strs Ohio now owns 408,452 shares of the company's stock worth $5,734,000 after acquiring an additional 266,400 shares in the last quarter. Finally, Reinhart Partners Inc. bought a new stake in shares of Enhabit in the third quarter worth about $4,153,000. Institutional investors own 95.55% of the company's stock.

Enhabit Price Performance

EHAB stock opened at $15.12 on Friday. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.63. The business has a 50-day moving average of $13.66 and a 200-day moving average of $14.37. Enhabit, Inc. has a fifty-two week low of $11.65 and a fifty-two week high of $25.25.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the company. UBS Group assumed coverage on Enhabit in a report on Thursday, December 8th. They issued a "sell" rating and a $12.00 price target for the company. Oppenheimer assumed coverage on Enhabit in a report on Thursday, October 13th. They issued a "market perform" rating for the company. CJS Securities assumed coverage on Enhabit in a report on Tuesday, December 13th. They issued a "market perform" rating and a $18.00 price target for the company. Credit Suisse Group lowered their price target on Enhabit from $19.00 to $15.00 and set a "neutral" rating for the company in a report on Friday, November 4th. Finally, Stifel Nicolaus started coverage on Enhabit in a report on Monday, December 5th. They issued a "buy" rating and a $17.00 price target for the company. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $16.43.

Insider Activity at Enhabit

In related news, Director Gregory S. Rush purchased 8,300 shares of Enhabit stock in a transaction that occurred on Monday, November 7th. The stock was purchased at an average cost of $12.69 per share, with a total value of $105,327.00. Following the completion of the transaction, the director now owns 16,597 shares of the company's stock, valued at approximately $210,615.93. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other Enhabit news, Director Jeffrey Bolton acquired 2,000 shares of the company's stock in a transaction on Wednesday, November 9th. The shares were purchased at an average price of $12.75 per share, for a total transaction of $25,500.00. Following the completion of the purchase, the director now directly owns 14,597 shares of the company's stock, valued at $186,111.75. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Gregory S. Rush acquired 8,300 shares of the company's stock in a transaction on Monday, November 7th. The stock was acquired at an average price of $12.69 per share, for a total transaction of $105,327.00. Following the purchase, the director now directly owns 16,597 shares of the company's stock, valued at $210,615.93. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 13,000 shares of company stock valued at $164,903.

Enhabit Company Profile

(Get Rating)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Read More

• Get a free copy of the StockNews.com research report on Enhabit (EHAB)
• MarketBeat Week in Review – 1/23- 1/27
• Why Lucid Spiked Nearly 100% In One Day
• Ride These Railroad Stocks for Growth and Income
• ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
• KLA Corporation: Strength In A Troubled Semi-Market

Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHAB – Get Rating).

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.